STSA-1002

· Staidson (Beijing) Biopharmaceuticals Co., Ltd

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for STSA-1002, covering 2024-05-22 to 2026-01-02. Get the full timeline:

Most recent: Clinical Trial Update: To Evaluate The Safety and Efficacy of STSA-1002 Injection in Patients With Acute Respiratory Distress Syndrome [Phase 3]

See pricing